78 related articles for article (PubMed ID: 8200275)
1. [Multiple gene alterations in human esophageal squamous cell carcinoma].
Liang YY
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):408-11. PubMed ID: 8200275
[TBL] [Abstract][Full Text] [Related]
2. [Alterations of oncogenes in human fetal esophageal epithelium induced by N-methylbenzylnitrosamine (NMBzA)].
Guo YJ; Lu SX; Liang YY
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):407-10. PubMed ID: 7720492
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
4. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of c-myc gene in esophageal squamous cell carcinoma].
He J; Zhang RG; Zhu D
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):94-6, 127. PubMed ID: 7767777
[TBL] [Abstract][Full Text] [Related]
6. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
[TBL] [Abstract][Full Text] [Related]
7. [Profile of p53 mutations and abnormal expression of P53 protein in 2 forms of esophageal cancer].
Muzeau F; Fléjou JF; Potet F; Belghiti J; Thomas G; Hamelin R
Gastroenterol Clin Biol; 1996; 20(5):430-7. PubMed ID: 8761140
[TBL] [Abstract][Full Text] [Related]
8. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
Cong DG; Wang SF
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
[TBL] [Abstract][Full Text] [Related]
9. [Multiple tumor suppressor 1/p16 gene alterations in human esophageal squamous-cell carcinoma: clinical significance and regional difference].
Lü G; Chen X; Cao W
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):359-62. PubMed ID: 11776574
[TBL] [Abstract][Full Text] [Related]
10. [Genomic changes in primary lesion and lymph node metastases of esophageal squamous cell carcinoma].
Qin YR; Wang LD; Dora K; Guan XY; Zhuang ZH; Fan ZM; Deng W; Cao SH
Ai Zheng; 2005 Sep; 24(9):1048-53. PubMed ID: 16159423
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of p53 in esophageal squamous cell carcinoma.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
[TBL] [Abstract][Full Text] [Related]
12. [Deletion of MTS1/p16 gene in human esophageal carcinoma].
Jin S; Peng Q; Lu S
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):9-11. PubMed ID: 10921045
[TBL] [Abstract][Full Text] [Related]
13. Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas.
Huang Y; Meltzer SJ; Yin J; Tong Y; Chang EH; Srivastava S; McDaniel T; Boynton RF; Zou ZQ
Cancer Res; 1993 Apr; 53(8):1889-94. PubMed ID: 8467510
[TBL] [Abstract][Full Text] [Related]
14. Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Yokomakura N; Kita Y; Matsumoto M; Uchikado Y; Setoyama T; Owaki T; Ishigami S; Aikou T
Clin Cancer Res; 2006 Jun; 12(12):3740-5. PubMed ID: 16778101
[TBL] [Abstract][Full Text] [Related]
15. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality.
Bitzer M; Stahl M; Arjumand J; Rees M; Klump B; Heep H; Gabbert HE; Sarbia M
Anticancer Res; 2003; 23(2B):1489-93. PubMed ID: 12820414
[TBL] [Abstract][Full Text] [Related]
16. [Possible significance of novel DNA fragments frequently deleted from tumor cell lines of human esophageal cancer].
Hou P; Zheng J; Wang Z
Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):336-8. PubMed ID: 10920910
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas.
Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM
Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897
[TBL] [Abstract][Full Text] [Related]
18. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis.
Miyake S; Nagai K; Yoshino K; Oto M; Endo M; Yuasa Y
Cancer Res; 1994 Jun; 54(11):3007-10. PubMed ID: 8187090
[TBL] [Abstract][Full Text] [Related]
19. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
[TBL] [Abstract][Full Text] [Related]
20. p53 protein expression in resected invasive esophageal cancer.
Chyczewski L; Kozłowski M; Nikliński J; Szyszko J; Laudański J; Niklińska W
Neoplasma; 1999; 46(3):150-5. PubMed ID: 10613589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
